ArticleCancers2025

Impact of Chemotherapy Dose Intensity on Pathological Complete Response in Pembrolizumab-Treated Early Triple-Negative Breast Cancer: A Real-World Multicenter Analysis.

Palma Fedele et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.